Medicare Benefits Schedule - Item 73410

Search Results for Item 73410

View Associated Notes

Category 6 - PATHOLOGY SERVICES

73410

73410 - Additional Information

Item Start Date:
01-Jul-2022
Description Updated:
01-Jul-2024
Schedule Fee Updated:
01-Jul-2022

Group
P7 - Genetics

Deletion testing of HBA1 and HBA2 for:

(a) the diagnosis of alpha thalassaemia in a patient of reproductive age:

(i) who has abnormal red cell indices; and

(ii) for whom thalassaemia screening was suggestive of thalassaemia; and

(iii) who does not have a concurrent iron deficiency (or who, irrespective of iron status, is pregnant); and

(iv) who has no historic normal cell indices; or

(b) the determination of carrier status in a person:

(i) who is a reproductive partner of a person with alpha thalassaemia; and

(ii) who has abnormal red cell indices; and

(iii) who does not have a concurrent iron deficiency; or

(c) the determination of carrier status in a person:

(i) who is a reproductive partner of a person with alpha thalassaemia and heterozygous 2‑gene deletion; and

(ii) who has normal red cell indices

Fee: $100.00 Benefit: 75% = $75.00 85% = $85.00

(See para PN.7.5 of explanatory notes to this Category)


Associated Notes

Category 6 - PATHOLOGY SERVICES

PN.7.5

'Abnormal red cell indices' for the purpose of genetic testing for thalassaemia and item 73410

‘Abnormal red cell indices’ refers to a mean corpuscular volume <80 fL and/or mean corpuscular haemoglobin <28 pg and haematological studies suggestive of thalassaemia.

Related Items: 73410


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change